Concepedia

Stephen Thein

ST

14

Publications

1.5K

Citations

14

H-Index

2001

Active since

Affiliations

Research Network (United States)(Current)

Stanford Medicine

NeuroTrials Research (United States)

GlaxoSmithKline (United States)

Research Triangle Park Foundation

Stephen Thein is an author at Research Network (United States) specializing in medicine, pharmacotherapy, and dementia.

Top concepts

Publications per year

2001–2023

14

Publications

14

Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease

Vladimir Coric, Christopher H. van Dyck, Stephen Salloway et al. · Archives of Neurology · 2012 · 363 citations

Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial

Paula K. Schweitzer, Russell Rosenberg, Gary Zammit et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 305 citations · Full text

Targeting Prodromal Alzheimer Disease With Avagacestat

Vladimir Coric, Stephen Salloway, Christopher H. van Dyck et al. · JAMA Neurology · 2015 · 229 citations · Full text

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

Daniel K. Burns, Robert Alexander, Kathleen A. Welsh‐Bohmer et al. · The Lancet Neurology · 2021 · 108 citations

, , +11

Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder

Dieter Kunz, Yves Dauvilliers, Heike Beneš et al. · CNS Drugs · 2022 · 84 citations · Full text

Rows per page

1–5 of 14